Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trialKazumoto Iijima, Yasuo Ohashi, Hidefumi Nakamura et al.|The Lancet|2014Cited by 450